Greenland Mines Ltd (GRML)
This price reflects trading activity during the overnight session on the Blue Ocean ATS, available 8 PM to 4 AM ET, Sunday through Thursday, when regular markets are closed.
Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
|
Dr. Joseph A. Sinkule Pharm.D.
|
Founder, CEO, Chairman of the Board & Secretary | 565k | -- | 1954 |
|
Mr. Jeffrey LeBlanc
|
Chief Financial Officer | 485k | -- | 1977 |
|
Mr. Peter J. Moriarty
|
Chief Business Officer | 150k | -- | 1950 |
|
Dr. Bo Moller Stensgaard
|
President | -- | -- | 1975 |
|
Dr. Miguel Chillon Rodriguez
|
Chief Scientific Officer & Consultant | -- | -- | 1966 |
|
Dr. Gustavo L.A. Delendatti B.Sc (Hons), MAIG, Ph.D.
|
Vice President of Exploration | -- | -- | -- |
|
Dr. Jakob Kløve Keiding
|
Chief Geologist | -- | -- | -- |
Greenland Mines Ltd
- Sector:
- Basic Materials
- Industry: Other Precious Metals & Mining
- Full Time Employees:
- 5
Description
Greenland Mines Ltd engages in the cell and gene therapy, and natural resources businesses. The company primarily explores palladium, gold, and platinum deposits. It focuses on the exploration and development of Skaergaard project located in Southeast Greenland and the Sarartoq neodymium-praseodymium (Nd-Pr) rare earths project in Southwest Greenland. The company is also involved in the development of KLTO-202, a gene therapy for the treatment and prevention of amyotrophic lateral sclerosis; and KLTO-101 for the treatment or prevention of Alzheimer's disease, as well as therapies to treat Parkinson's and other age-related disorders. The company was formerly known as Klotho Neurosciences, Inc. and changed its name to Greenland Mines Ltd in March 2026. Greenland Mines Ltd is based in Charlotte, North Carolina.
Corporate Governance
Upcoming Events
Upcoming Events Information Not Available
